An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world's third ...

Pharmacogenomics (PGx) involves the study of patients’ unique genes to predict their individual response to drugs. 1,3 In assessments of the 12 most important pharmacogenes, at least 1 clinically ...

In a recent article published in the Genes Journal, researchers discussed the significance of pharmacogenomics-based studies in the research for personalized therapeutics for dementia, including drugs ...

David Skomo, and Nick Page, PharmD, of WellDyne offered their perspectives on recent developments in precision medicine at the 2022 Asembia Specialty Pharmacy Summit. Representatives from WellDyne, a ...

Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...

New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system investigates the multifaceted implementation of pharmacogenomics—a rapidly evolving field ...

The science of pharmacogenomics, which aims to define the genetic determinants of drug effects, has evolved over the past 50 years. The idea that genes control some drug responses was suggested in the ...

Pharmacogenomics is the field of study about the effect of genes on an individual’s response to medications. It combines the science of drugs, which is known as pharmacology, with the study of genes, ...

The latter portion of the twentieth century witnessed the emergence of the concept that inheritance is a major factor responsible for variation in drug response. Once that principle had been ...